Along with this, early studies indicated that either overexpression of CXCL9 by cancer cell lines [203], or direct injection of CXCL10 to the tumor site [204], or targeted gene therapy of CXCL10 [205], may limit cancer development. The gene discussed is CXCL10; the disease is neoplasm.